More than 500 million people around the world live with osteoarthritis. The knee is affected more often than any other joint, ...

Post-traumatic osteoarthritis (PTOA) is a condition that affects joints after an injury. Current treatments focus on ...

The University of Manchester and Link Biologics Limited today announced the publication of preclinical data on a potential new treatment for Osteoarthritis in the peer-reviewed journal, Osteoarthritis ...

The drug is called methotrexate. It’s not new—it’s been around since the 1980s and is commonly used to treat autoimmune ...

Acupressure performed by patients on their own was at least somewhat effective for relieving symptoms of knee osteoarthritis ...

UK-based MSK Doctors (4403300010048), a premier platform connecting patients with expert musculoskeletal doctors and surgeons ...

Low-dose radiation therapy (LD-RT) has been used as a treatment in Europe for decades to reduce pain and inflammation caused by osteoarthritis and other chronic musculoskeletal conditions.

Enlivex to receive Chinese patent for use of Allocetra as a potential treatment in patients with osteoarthritis: Nes-Ziona, Israel Wednesday, March 19, 2025, 10:00 Hrs [IST] Enliv ...

The Company expects that this new patent will be issued in China during the ... the first patent allowance for the use of Allocetra TM as a potential treatment in patients with osteoarthritis. We ...

Post-traumatic osteoarthritis (PTOA) is a condition that affects joints after an injury. Current treatments focus on relieving symptoms but do not prevent or stop the progression of the condition.